Asymptomatic carriers of clostridium difficile in serbian population

被引:5
作者
Stojanovic, Predrag [1 ,2 ]
Stojanovic, Nevena [3 ]
Kocic, Branislava [1 ,2 ]
Stankovic-Dordevic, Dobrila [1 ,2 ]
Babic, Tatjana [2 ]
Stojanovic, Kristina [4 ]
机构
[1] Fac Med, Dept Microbiol, Nish 18000, Serbia
[2] Inst Publ Hlth Nis, Ctr Microbiol, Nish 18000, Serbia
[3] Gynecol Obstet Clin, Dept Neonatol, Nish 18000, Serbia
[4] Clin Centar, Nish 18000, Serbia
来源
CENTRAL EUROPEAN JOURNAL OF MEDICINE | 2012年 / 7卷 / 06期
关键词
Clostridium difficile; Asymptomatic intestinal carriers; Children; Hospitalized patients; Medical staff; TERM-CARE FACILITIES; NOSOCOMIAL ACQUISITION; RISK-FACTORS; COLONIZATION; PREVALENCE; RESIDENTS; DIARRHEA; INFANTS; TRANSMISSION; INFECTION;
D O I
10.2478/s11536-012-0067-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the research was to determine the intestinal carriers of C. difficile in different human population groups in Serbia. The research enrolled 877 persons with formed stools: (newborn children in maternity hospitals for up to two weeks old) (23), group A; children aged from two weeks to two years (121), group B; children aged two to 10 years (54), group C, healthy individuals aged 10 and over (516), group D; patients hospitalized for at least 48 hours (100), group E; staff of the Clinical Center in Nis, Serbia, (63), group F. The toxins A and B of C. difficile were detected by ELISA-ridascreen Clostridium difficile Toxin A/B (R - Biopharm AG, Darmstadt, Germany). The toxin A of C. difficile was detected using ColorPAC Toxin A test (BectonDickinson, New Jersey, USA). Out of the total number of persons (877), the carriers of certain types of toxin-producing strains of C. difficile were distributed as: 6.04% (A-/B-), 1.83% (A+/B+) and 0.11% (A-/B+). In most groups (5/6), the dominance of non-toxigenic (A-/B-) isolates was established, with the rate of carriers 1.75 - 30.43% depending on the group. Toxigenic isolates were prevalent only in the group F in relation to non - toxigenic (7.94% versus 4.76% of persons). In other groups, the carriers of toxigenic strains ranged from 0.00 - 17.45%. The presence of asymptomatic intestinal carriers of C. difficile in the human population, indicate the possible reservoirs and sources of infection.
引用
收藏
页码:769 / 774
页数:6
相关论文
共 20 条
  • [1] Treatment of Clostridium difficile-associated disease:: old therapies and new strategies
    Aslam, S
    Hamill, R
    Musher, DM
    [J]. LANCET INFECTIOUS DISEASES, 2005, 5 (09) : 549 - 557
  • [2] BOLTON RP, 1984, ARCH DIS CHILD, V59, P466, DOI 10.1136/adc.59.5.466
  • [3] Clinical manifestations, treatment and control of infections caused by Clostridium difficile
    Bouza, E
    Muñoz, P
    Alonso, R
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 : 57 - 64
  • [4] BROOKS SE, 1992, INFECT CONT HOSP EP, V13, P98
  • [5] Clabots R, 1992, J INFECT DIS, V166, P561
  • [6] ELMOHANDES AE, 1993, BIOL NEONATE, V63, P225
  • [7] Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis
    Kato, H
    Kita, H
    Karasawa, T
    Maegawa, T
    Koino, Y
    Takakuwa, H
    Saikai, T
    Kobayashi, K
    Yamagishi, T
    Nakamura, S
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 50 (08) : 720 - 727
  • [8] Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea
    Kyne, L
    Warny, M
    Qamar, A
    Kelly, CP
    [J]. LANCET, 2001, 357 (9251) : 189 - 193
  • [9] LARSON HE, 1978, LANCET, V1, P1063
  • [10] EPIDEMIOLOGY OF CLOSTRIDIUM-DIFFICILE IN INFANTS
    LARSON, HE
    BARCLAY, FE
    HONOUR, P
    HILL, ID
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (06) : 727 - 733